Invokana Litigation Alleging Kidney and Ketoacidosis Injuries Could Become an MDL (Multidistrict Litigation)

Medical Drug Safety

Last week, a motion was filed requesting multidistrict litigation (MDL) for lawsuits of individuals with kidney damage or diabetic ketoacidosis from taking the prescription, Invokana. Invokana (canagliflozin) is an oral prescription used to help lower blood glucose in patients with type 2 diabetes. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the…

Read More